{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:23:18Z","timestamp":1793118198365,"version":"4.5.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To characterize acute megakaryocytic leukemia (FAB M7 AML), we identified 37 patients with M7 AML treated at M.D. Anderson Cancer Center between 1987 and 2003 and compared them with 1800 patients with non-M7, non-M3 AML treated during the same period. The median age of the M7 AML group was 56 years (range, 21-78 years); 22 patients (59%) had an antecedent hematologic disorder or myelodysplastic syndrome or both, and 7 patients (19%) had previously received chemotherapy for other malignancies. Extensive bone marrow fibrosis was found in 23 patients (62%). Poor cytogenetic characteristics were observed in 49% of patients with M7 AML versus 33% of others (P &lt; .001). Complete remission rates were 43% with M7 AML and 57% with non-M7 AML (P = .089). Median overall survival (OS) was 23 and 38 weeks, respectively (P = .006). Median disease-free survivals were 23 versus 52 weeks, respectively (P &lt; .001). By multivariate analysis, M7 AML was an independent adverse prognostic factor for OS, independent of other factors including cytogenetic abnormalities (hazard ratio 1.51, P = .049). These results confirm the poor prognosis of M7 AML and indicate that other biologic characteristics beyond cytogenetic abnormalities likely play a role in this disease.<\/jats:p>","DOI":"10.1182\/blood-2005-06-2450","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T00:34:00Z","timestamp":1125016440000},"page":"880-884","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center"],"prefix":"10.1182","volume":"107","author":[{"given":"Yasuhiro","family":"Oki","sequence":"first","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhou","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Faderl","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O'Brien","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Koller","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miloslav","family":"Beran","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Nebiyou","family":"Bekele","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Pierce","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Ravandi","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Wierda","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Giles","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jabbour","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elihu","family":"Estey","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[{"name":"From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711120104300_REF1","unstructured":"Von Boros J, Korenyi A. Uber einen fall von akuter megakaryocyblasten-leukamie, zugleich einige bemerkungen zum Problem der akuten leukemie. Z Klin Med. 1931;118: 679-718."},{"key":"2019111711120104300_REF2","doi-asserted-by":"crossref","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103: 460-462.","DOI":"10.7326\/0003-4819-103-3-460"},{"key":"2019111711120104300_REF3","doi-asserted-by":"crossref","unstructured":"Athale UH, Razzouk BI, Raimondi SC, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood. 2001;97: 3727-3732.","DOI":"10.1182\/blood.V97.12.3727"},{"key":"2019111711120104300_REF4","doi-asserted-by":"crossref","unstructured":"Pagano L, Pulsoni A, Vignetti M, et al. Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia. 2002;16: 1622-1626.","DOI":"10.1038\/sj.leu.2402618"},{"key":"2019111711120104300_REF5","unstructured":"Tallman MS, Neuberg D, Bennett JM, et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood. 2000;96: 2405-2411."},{"key":"2019111711120104300_REF6","doi-asserted-by":"crossref","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103: 620-625.","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"2019111711120104300_REF7","doi-asserted-by":"crossref","unstructured":"Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92: 2322-2333.","DOI":"10.1182\/blood.V92.7.2322"},{"key":"2019111711120104300_","doi-asserted-by":"crossref","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood. 2000;96: 4075-4083.","DOI":"10.1182\/blood.V96.13.4075"},{"key":"2019111711120104300_REF9","doi-asserted-by":"crossref","unstructured":"Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100: 4325-4336.","DOI":"10.1182\/blood-2002-03-0772"},{"key":"2019111711120104300_REF10","doi-asserted-by":"crossref","unstructured":"Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8: 813-819.","DOI":"10.1200\/JCO.1990.8.5.813"},{"key":"2019111711120104300_REF11","doi-asserted-by":"crossref","unstructured":"Estey EH, Thall PF, Wang X, Verstovsek S, Cortes J, Kantarjian HM. Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML. Blood. 2003;102: 3097-3099.","DOI":"10.1182\/blood-2003-04-1309"},{"key":"2019111711120104300_REF12","unstructured":"Snedecor G, Cochran W. Statistical Methods. 7th ed. Ames, IA: Iowa State University Press; 1980."},{"key":"2019111711120104300_REF13","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meire P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"2019111711120104300_REF14","unstructured":"Agresti A. Categorical Data Analysis. New York, NY: Wiley Series; 1990."},{"key":"2019111711120104300_REF15","doi-asserted-by":"crossref","unstructured":"Cox D. Regression models and life tables. J R Stat Soc. 1972;34: 187-202.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2019111711120104300_REF16","doi-asserted-by":"crossref","unstructured":"Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer. 1977;35: 1-39.","DOI":"10.1038\/bjc.1977.1"},{"key":"2019111711120104300_REF17","doi-asserted-by":"crossref","unstructured":"Bauermeister DE. Quantitation of bone marrow reticulin\u2014a normal range. Am J Clin Pathol. 1971;56: 24-31.","DOI":"10.1093\/ajcp\/56.1.24"},{"key":"2019111711120104300_REF18","doi-asserted-by":"crossref","unstructured":"Nichols CR, Hoffman R, Einhorn LH, Williams SD, Wheeler LA, Garnick MB. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med. 1985;102: 603-609.","DOI":"10.7326\/0003-4819-102-5-603"},{"key":"2019111711120104300_REF19","doi-asserted-by":"crossref","unstructured":"Duchayne E, Fenneteau O, Pages MP, et al. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Francais d'Hematologie Cellulaire (GFHC). Leuk Lymphoma. 2003;44: 49-58.","DOI":"10.1080\/1042819021000040279"},{"key":"2019111711120104300_REF20","doi-asserted-by":"crossref","unstructured":"Garderet L, Labopin M, Gorin NC, et al. Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2005;105: 405-409.","DOI":"10.1182\/blood-2004-03-1103"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/880\/1280512\/zh800306000880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/880\/1280512\/zh800306000880.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T16:12:16Z","timestamp":1574007136000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/3\/880\/22132\/Adult-acute-megakaryocytic-leukemia-an-analysis-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-06-2450","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}